Effect of oxygen therapy in preventing contrast nephropathy

The study of oxygen therapy in preventing contrast nephropathy in patients with acute coronary syndrome undergoing emergent angiography refereed to Resoul Akram hospital in 2018

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190317043082N1

Enrollment

204

Registered

2019-04-05

Start date

2018-08-12

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Acute ischemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: : This group received 2 to 3 liters of oxygen per minute from the 10 minutes before the start of the procedure until the end of the procedure. ABG were taken prior

Eligibility

Sex/Gender

All

Age

35 Years to No maximum

Inclusion criteria

Inclusion criteria: Male or female patients over 35 years old Suspected of coronary artery disease

Exclusion criteria

Exclusion criteria: Arterial oxygen saturation less than 90% Having end stage renal disease Patients undergoing dialysis coronary artery bypass surgery Candidate for emergency coronary artery bypass surgery

Design outcomes

Primary

Measure	Time frame
Serum creatinine level. Timepoint: Before the procedure and 48 hours later. Method of measurement: Blood sampling.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Zarouk Ahi Mahalleh

Tehran University of Medical Sciences

zarouk.t@iums.ac.ir+98 21 8889 6692

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026